Nasdaq gave Arbe Robotics Ltd. an additional 180-calendar-day period, through April 12, 2027, to meet its $1.00-per-share minimum bid-price requirement. The company did not regain compliance during its initial period, which ended October 12, 2026. Nasdaq said Arbe meets the other applicable initial listing requirements for The Nasdaq Capital Market, including the market-value requirement for publicly held shares.
If Arbe’s ordinary shares close at or above $1.00 per share for at least 10 consecutive business days before April 12, 2027, Nasdaq will provide written confirmation of compliance and close the matter. Arbe is considering available options, including a reverse share split if necessary. Nasdaq said the notice has no immediate effect on the listing or trading of ARBE ordinary shares.
Arbe Robotics Ltd. director Eugene Scott Crist directly purchased 50,000 Ordinary Shares at $0.605 per share on September 28, 2026, and reported 1,014,182 shares following the purchase. The amendment corrects the previously reported share count and beneficial ownership after the transaction; no other changes were made. No Rule 10b5-1 plan is reported.
Arbe Robotics Ltd. warrants are covered by Nasdaq Stock Market LLC’s Form 25 notice of removal from listing and registration under Section 12(b) of the Securities Exchange Act of 1934.
Arbe Robotics Ltd. director Eugene Scott Crist purchased 50 ordinary shares at $0.6050 per share on September 28, 2026, and reported 1,014,182 shares held directly afterward. He also reported 340,000 shares held by Texas Ventures Mgmt, LLC, over which he has voting and dispositive power. Crist disclaims beneficial ownership of those securities except to the extent of his pecuniary interest. No Rule 10b5-1 plan is reported.
Arbe Robotics Ltd. (ARBE) priced an underwritten registered direct offering of 833,334 ordinary shares at $0.60 per share and pre-funded warrants to purchase up to 24,166,666 ordinary shares at $0.5999 per warrant. The warrants have a $0.0001-per-share exercise price and are immediately exercisable, including through cashless exercise.
Gross proceeds are estimated at approximately $15.0 million before underwriting discounts, commissions and offering expenses. Arbe intends to use net proceeds for working capital and general corporate purposes, including scaling operations for commercial opportunities, expanding into defense and counter-drone markets, and potentially pursuing strategic merger and acquisition opportunities. The company agreed to pay underwriting commissions and discounts equal to 6.0% of gross proceeds and reimburse $125,000 of expenses.
The offering is expected to close on or about September 28, 2026, subject to customary closing conditions. Warrant exercises are subject to beneficial-ownership and voting-power limits of 4.99% or 9.99%; a holder may change the applicable percentage on 61 days’ notice, to a level not exceeding 9.99%.
Arbe Robotics Ltd. entered into warrant amendment agreements on September 25, 2026, with holders of all outstanding Tranche A and Tranche B ordinary share purchase warrants. Each tranche covers up to an aggregate of 8,131,866 ordinary shares.
Under the agreements, the company agreed to reduce Tranche A’s exercise price to $1.10 per ordinary share and extend its termination date to November 4, 2030. For Tranche B, it agreed to reduce the exercise price to $1.00 per ordinary share and extend its termination date to November 4, 2029. The warrants were originally issued on November 4, 2024.
Arbe Robotics Ltd. (ARBE) reported that director Yair Shamir received a grant of 120,000 stock options on September 9, 2026 under the company’s 2021 Share Incentive Plan. The options have an exercise price of $0.7045 per Ordinary Share, expire on September 9, 2036, and vest in twelve equal three-month installments beginning December 9, 2026, subject to his continued service.
Arbe Robotics Ltd. (symbol: ARBE) is the issuer of record for a Form 4 filing submitted to the SEC. Marinka Jacob reported disposition transactions in this Form 4 filing.
Arbe Robotics Ltd. (ARBE) reported that director and President Marinka Jacob received an equity award of 100,000 restricted ordinary shares under the company's 2021 Share Incentive Plan, at a stated price of $0.00 per share. These restricted shares vest in full on April 1, 2027, subject to Jacob's continued service to Arbe Robotics or its subsidiaries through that date, and are subject to forfeiture until vesting. The award was approved by the board on April 22, 2026 subject to shareholder approval and was subsequently approved by shareholders at the annual general meeting held on September 9, 2026. Following this award, Jacob holds 1,991,732 ordinary shares directly, and no Rule 10b5-1 trading plan is reported in connection with this grant.
Arbe Robotics Ltd. (ARBE) reported that director Eugene Scott Crist received a grant of 120,000 stock options on September 9, 2026 under the company’s 2021 Share Incentive Plan. The options have an exercise price of $0.7045 per share, expire on September 9, 2036, and are currently held as a direct derivative position.
According to the grant terms, the options vest in twelve equal three‑month installments starting on December 9, 2026, contingent on Mr. Crist’s continued service with Arbe Robotics or its subsidiaries through each vesting date. The filing indicates the transaction was made under a Rule 10b5-1 trading plan.
Arbe Robotics Ltd. (symbol: ARBE) is the issuer of record for a Form 4 filing submitted to the SEC. Machness Ram reported disposition transactions in this Form 4 filing.
Arbe Robotics Ltd. (ARBE) reported that Chief Executive Officer and director Ram Machness filed a Form 4 reflecting a transaction in 1,125,000 restricted ordinary shares under the company’s 2021 Share Incentive Plan. These restricted shares vest over three years, are subject to forfeiture until vesting, and require continued service through each vesting date.
The award was approved by the board and subsequently approved by shareholders at the annual general meeting held on September 9, 2026. Following this reported transaction, Machness directly holds 1,470,195 restricted shares. No Rule 10b5-1 trading plan is reported in connection with this filing.